Why it matters:
The breakthrough offers a cutting-edge solution for bone tissue repair, reducing surgical complications and enhancing healing. The research underscores Iran’s commitment to advancing medical sciences and biotechnology despite Western sanctions.
What she's saying:
Dr. Mehri Sohrabi, stated: "Bone is one of the most studied tissues in regenerative medicine. While it has natural healing capabilities, severe injuries can disrupt the highly organized bone formation process. Injectable pastes eliminate many challenges posed by conventional bone graft materials, such as difficulties in shaping and migration to adjacent tissues. Our innovation improves drug delivery control, making it ideal for non-invasive surgeries and complex bone defects."
Key points:
- The research integrates quercetin, a bioactive agent known for enhancing bone density, into an injectable bioactive glass paste.
- The injectable paste improves bone healing, biocompatibility, and drug delivery while ensuring minimal surgical intervention.
- The development aligns with Iran’s strategic focus on self-sufficiency in medical technologies and reducing dependency on foreign imports.
Go deeper:
Bioactive materials like hydroxyapatite and bioactive glass have long been used in bone and dental repair. The research introduces a novel approach by combining quercetin with injectable scaffolds, enabling faster and more efficient healing. The findings set a foundation for further developments in tissue engineering and regenerative medicine, reinforcing Iran’s standing as a leader in scientific progress within the region.
206
